1. Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial. Issue 10 (October 2021) Authors: Ruckwardt, Tracy J; Morabito, Kaitlyn M; Phung, Emily; Crank, Michelle C; Costner, Pamela J; Holman, LaSonji A; Chang, Lauren A; Hickman, Somia P; Berkowitz, Nina M; Gordon, Ingelise J; Yamshchikov, Galina V; Gaudinski, Martin R; Lin, Bob; Bailer, Robert; Chen, Man; Ortega-Villa, Ana M; Nguyen, T... Journal: Lancet Issue: Volume 9:Issue 10(2021) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial. (June 2022) Authors: Houser, Katherine V.; Gaudinski, Martin R.; Happe, Myra; Narpala, Sandeep; Verardi, Raffaello; Sarfo, Edward K.; Corrigan, Angela R.; Wu, Richard; Rothwell, Ro Shauna; Novik, Laura; Hendel, Cynthia S.; Gordon, Ingelise J.; Berkowitz, Nina M.; Cartagena, Cora Trelles; Widge, Alicia T.; Coates, Emi... Journal: EClinicalMedicine Issue: Volume 48(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial. Issue 8 (August 2022) Authors: Coates, Emily E; Edupuganti, Srilatha; Chen, Grace L; Happe, Myra; Strom, Larisa; Widge, Alicia; Florez, Maria Burgos; Cox, Josephine H; Gordon, Ingelise; Plummer, Sarah; Ola, Abidemi; Yamshchikov, Galina; Andrews, Charla; Curate-Ingram, Sharon; Morgan, Patricia; Nagar, Shashi; Collins, Matthew H... Journal: Lancet infectious diseases Issue: Volume 22:Issue 8(2022) Page Start: 1210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention. (4th February 2022) Authors: Mahomed, Sharana; Garrett, Nigel; Capparelli, Edmund V; Osman, Farzana; Harkoo, Ishana; Yende-Zuma, Nonhlanhla; Gengiah, Tanuja N; Archary, Derseree; Samsunder, Natasha; Baxter, Cheryl; Mkhize, Nonhlanhla N; Modise, Tandile; Carlton, Kevin; McDermott, Adrian; Moore, Penny L; Karim, Quarraisha Abd... Journal: Journal of infectious diseases Issue: Volume 226:Number 3(2022) Page Start: 510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study. Issue 10174 (2nd March 2019) Authors: Gaudinski, Martin R; Coates, Emily E; Novik, Laura; Widge, Alicia; Houser, Katherine V; Burch, Eugeania; Holman, LaSonji A; Gordon, Ingelise J; Chen, Grace L; Carter, Cristina; Nason, Martha; Sitar, Sandra; Yamshchikov, Galina; Berkowitz, Nina; Andrews, Charla; Vazquez, Sandra; Laurencot, Carolyn... Journal: Lancet Issue: Volume 393:Issue 10174(2019) Page Start: 889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Analytical characterization of broadly neutralizing antibody CAP256LS heavy chain clipping during manufacturing development. (29th August 2022) Authors: Gollapudi, Deepika; Rosales‐Zavala, Erwin; Ivleva, Vera B.; Yang, Yanhong; Li, Yile; O'Connell, Sarah; Doria‐Rose, Nicole A.; Patel, Aakash; Blackstock, Daniel; Gowetski, Daniel B.; Carlton, Kevin; Gall, Jason G. D.; Lei, Q. Paula Journal: Biotechnology progress Issue: Volume 38:Number 6(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial. Issue 11 (26th November 2020) Authors: Mahomed, Sharana; Garrett, Nigel; Karim, Quarraisha A; Zuma, Nonhlanhla Y; Capparelli, Edmund; Baxter, Cheryl; Gengiah, Tanuja; Archary, Derseree; Samsunder, Natasha; Rose, Nicole D; Moore, Penny; Williamson, Carolyn; Barouch, Dan H; Fast, Patricia E; Pozzetto, Bruno; Hankins, Catherine; Carlton,... Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention. Issue 1 (1st January 2021) Authors: Kwon, Young D.; Asokan, Mangaiarkarasi; Gorman, Jason; Zhang, Baoshan; Liu, Qingbo; Louder, Mark K.; Lin, Bob C.; McKee, Krisha; Pegu, Amarendra; Verardi, Raffaello; Yang, Eun Sung; Program, VRC Production; Carlton, Kevin; Doria-Rose, Nicole A.; Lusso, Paolo; Mascola, John R.; Kwong, Peter D. Journal: MAbs Issue: Volume 13:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency. Issue 1 (31st December 2023) Authors: Zhang, Baoshan; Gorman, Jason; Kwon, Young D.; Pegu, Amarendra; Chao, Cara W.; Liu, Tracy; Asokan, Mangaiarkarasi; Bender, Michael F.; Bylund, Tatsiana; Damron, Leland; Gollapudi, Deepika; Lei, Paula; Li, Yile; Liu, Cuiping; Louder, Mark K.; McKee, Krisha; Olia, Adam S.; Rawi, Reda; Schön, Arne; ... Journal: MAbs Issue: Volume 15:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial. Issue 4 (April 2023) Authors: Mahomed, Sharana; Garrett, Nigel; Capparelli, Edmund V; Osman, Farzana; Mkhize, Nonhlanhla N; Harkoo, Ishana; Gengiah, Tanuja N; Mansoor, Leila E; Baxter, Cheryl; Archary, Derseree; Yende-Zuma, Nonhlanhla; Samsunder, Natasha; Carlton, Kevin; Narpala, Sandeep; McDermott, Adrian B; Doria-Rose, Nico... Journal: Lancet Issue: Volume 10:Issue 4(2023) Page Start: e230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗